Lee Danner & Bass Inc. trimmed its position in shares of Roche Holding Ltd. (OTCMKTS:RHHBY) by 5.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 75,358 shares of the company’s stock after selling 4,040 shares during the period. Lee Danner & Bass Inc.’s holdings in Roche were worth $2,380,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Mechanics Bank Trust Department acquired a new stake in Roche during the fourth quarter worth about $215,000. Murphy Capital Management Inc. acquired a new stake in Roche during the fourth quarter worth about $216,000. Stonebridge Capital Advisors LLC acquired a new stake in Roche during the third quarter worth about $221,000. Gofen & Glossberg LLC IL acquired a new stake in Roche during the fourth quarter worth about $267,000. Finally, Kovack Advisors Inc. acquired a new stake in Roche during the fourth quarter worth about $445,000. Hedge funds and other institutional investors own 0.58% of the company’s stock.

Roche Holding Ltd. (OTCMKTS:RHHBY) opened at $30.00 on Monday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.29 and a quick ratio of 0.92. Roche Holding Ltd. has a fifty-two week low of $28.48 and a fifty-two week high of $36.82.

A number of research analysts have recently commented on RHHBY shares. ValuEngine raised shares of Roche from a “hold” rating to a “buy” rating in a report on Tuesday, January 16th. Zacks Investment Research raised shares of Roche from a “hold” rating to a “buy” rating and set a $35.00 target price for the company in a report on Tuesday, January 2nd. Piper Jaffray Companies reiterated a “buy” rating on shares of Roche in a report on Thursday, December 7th. Berenberg Bank lowered shares of Roche from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Finally, Citigroup lowered shares of Roche from a “buy” rating to a “neutral” rating in a report on Wednesday, October 18th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the stock. Roche has an average rating of “Hold” and a consensus price target of $36.50.

ILLEGAL ACTIVITY WARNING: “Lee Danner & Bass Inc. Has $2.38 Million Holdings in Roche Holding Ltd. (RHHBY)” was posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.watchlistnews.com/lee-danner-bass-inc-has-2-38-million-holdings-in-roche-holding-ltd-rhhby/1846393.html.

About Roche

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding Ltd. (OTCMKTS:RHHBY).

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.